Elmiron Lawsuit | Vision Loss Attorneys

Thousands have already filed an Elmiron lawsuit after experiencing retinal toxicity and vision loss.

Quick Facts About Elmiron Vision Loss

Elmiron (pentosan polysulfate sodium) was FDA-approved in 1996 to treat interstitial cystitis. Since then, thousands of patients have filed MDL No. 2973 lawsuits alleging pigmentary maculopathy and retinal toxicity.

  • FDA Approval (1996): Pentosan polysulfate sodium was cleared by the FDA for interstitial cystitis in June 1996.
  • MDL 2973 Status: Over 1,000 cases are currently pending in the New Jersey MDL as of May 2025, with bellwether trial schedules now issued.
  • Main Injury: Pigmentary maculopathy – characterized by progressive vision distortion, difficulty reading, night blindness, and color fading.
  • Prescription Volume: More than 300,000 patients received Elmiron prescriptions between 1996–2022, according to IMS Health data.
  • Statute of Limitations: Most states give you 1–4 years from the date you first diagnosed pigmentary maculopathy to file a claim.

FREE ELIMRON CASE REVIEW

CALL NOW:  1-866-374-0338

Do You Qualify for an Elmiron Lawsuit?

Medical Criteria

Most claimants meet at least one of the following:

  • Took Elmiron for six months or longer (any year 1996 – present)
  • Diagnosed with pigmentary maculopathy, retinal toxicity, or PPS-maculopathy
  • Experiencing blurry vision, muted colours, night blindness, or similar eye problems
  • No pre-existing eye disease that fully explains these symptoms
  • Willing to provide pharmacy records and recent retinal scans

Preferred Documentation

If you don’t yet have these, our team can help you secure them

  • Pharmacy records showing Elmiron prescriptions
  • Recent retinal scans (OCT, OCT-A or fundus photos)
  • Any ophthalmologist’s notes or diagnostic reports
  • No pre-existing eye disease that fully explains these symptoms
  • Personal timeline of when your vision changed

Not sure if you have all the records? Get a free case review →

Have You Experienced These Symptoms?

Blurry or distorted vision
Blurry or distorted vision
Night blindness
Night blindness
Muted or faded colors
Muted or faded colors
Difficulty reading
Difficulty reading
Trouble seeing street signs or traffic lights
Trouble seeing street signs or traffic lights
Light sensitivity or halos around lights
Light sensitivity or halos around lights
Not sure? Get a free case review →

ALERT: Retinal damage can worsen even after you stop Elmiron. Act now to protect your rights.

Elmiron Lawsuit MDL Timeline

From May 2018 to June 2025, MDL 2973 has hit these four milestones. Nearly 1,000 active cases remain in the Elmiron lawsuit MDL 2973, with more being filed weekly.

may 2018

May 2018 – First Clinical Reports of Elmiron-Linked Maculopathy

Researchers at Vanderbilt and Emory published the very first case series describing pigmentary maculopathy in long-term Elmiron (pentosan polysulfate) patients, drawing a direct link between the drug and a distinctive retinal toxicity.
June 2020

June 2020 – FDA Adds Retinal‐Damage Warning to Elmiron Label

After mounting post-marketing reports, Janssen updates Elmiron’s prescribing information to include “changes in the retina of the eye (pigmentary maculopathy).”
dec 2020

December 15 2020 – MDL 2973 Centralized in New Jersey

The Judicial Panel on Multidistrict Litigation consolidates all federal Elmiron vision-injury lawsuits under MDL 2973 in the U.S. District Court for the District of New Jersey.
june 2025

June 2025 – Nearly 1,000 Active Elmiron Cases in MDL 2973

As of June 2025, there are 987 active vision-injury cases pending (1,986 filed total), marking the wind-down phase of the litigation.

Harmed by Elmiron?

Get answers. Get help. Start your free retina-scan review

Call Now!
1-866-374-0338

or

Get Started!
Request a callback online

With over 30 years of experience and more than $100 million recovered, The Johnson Law Firm has stood up to major drug manufacturers and won. We’re proud to represent clients across the U.S. in high-stakes litigation involving defective medications.

Real Results From Real Clients

“JLF took care of us excellently.  The outcome made our life a little more comfortable.  We couldn’t be happier with how they dealt with things and how the outcome was.”
— Daniel R. T.

Hands holding blurred eyeglasses symbolizing vision loss from Elmiron usage undergoing a Elmrion lawsuit

How an Elmiron Lawsuit Works

Elmiron are approved via FDA clinical trials, but real-world risks often emerge only after widespread use. When drug makers downplay side effects or fail to update warnings, they face liability under failure-to-warn and defective-design theories.

  • Signal Detection: Post-marketing data, medical-journal studies, ophthalmology journal reports, or FDA safety communications reveal unforeseen dangers.
  • MDL Coordination: Individual lawsuits are centralized to handle discovery efficiently while preserving unique damages.
  • Causation Proof: Pharmacologists, epidemiologists, and medical experts connect the drug to injuries such as vision loss, link between pentosan polysulfate sodium and retinal toxicity, gastroparesis, or blood clots.
  • Compensation: Covers past/future medical treatment, lost income, diminished quality of life, and, in some states, punitive damages for reckless conduct.
  • Deadlines: Typically two years from discovering the injury; we analyze prescription records to confirm eligibility.

From vision damage linked to Elmiron to complications from Ozempic or Depo-Provera, our legal team is ready to fight for the justice and compensation you deserve.

How We Help Elmiron Victims

At The Johnson Law Firm, we take a strategic, compassionate approach to every prescription drug injury case. Our process is designed to uncover the truth, hold negligent pharmaceutical companies accountable, and secure compensation for the harm you’ve endured.

Our Process:

  • Free Retina-Scan Review – We analyze your ophthalmology records to confirm pigmentary maculopathy.
  • Medical & Scientific Team – Engage pharmacologists retinal specialists and biostatisticians to strengthen causation.
  • Label & Marketing Analysis – Show how the manufacturer failed to warn physicians and patients.
  • Coordinated Litigation – File in the relevant drug MDL or state “judicial council coordinated proceeding” to maximize leverage.
  • Contingency-Fee Promise – You pay nothing unless we recover compensation.

Results-Driven Representation: You focus on recovery while we pursue maximum compensation—no fees unless we win.

Elmiron FAQs

A harmful prescription drug case typically involves a medication that caused unexpected side effects, injuries, or long-term health issues due to inadequate warnings, defective design, or pharmaceutical negligence. If you’ve experienced adverse effects from drugs like Elmiron, Ozempic, Fentanyl patches, or Depo-Provera, you may be eligible to file a claim.

If you took a prescription medication and later suffered complications not clearly disclosed by the manufacturer — such as vision loss, pancreatitis, blood clots, or neurological damage – you may have grounds for legal action. Contact our team for a free case evaluation to review your medical history and drug exposure.

Victims of defective or dangerous drugs may be entitled to compensation for:

  • Medical expenses (past and future)
  • Lost wages and reduced earning capacity
  • Pain and suffering
  • Permanent disability or life-altering side effects
  • Punitive damages (in cases of gross negligence)

Yes. Each state has a statute of limitations that sets a deadline for filing. In Texas, for example, victims typically have two years from the date of injury or discovery. However, every case is different – it’s crucial to speak with a qualified drug injury lawyer as soon as possible.

Not necessarily. Many harmful side effects appear months or even years after exposure. Whether the drug has been recalled or not, you may still have a claim if a link can be established between your injuries and the medication.

At The Johnson Law Firm, we work on a contingency fee basis, which means you pay nothing unless we win your case. Our legal fees come as a percentage of the settlement or award – and we cover all upfront costs during the litigation process.

Yes. Many prescription drug claims are handled as mass torts or consolidated into MDLs (multi-district litigation) for efficiency. These allow victims to pursue justice individually while benefiting from shared evidence and expert testimony. We’ll help you understand your best legal route.

Not sure if your eye problems are linked to Elmiron?

Our attorneys will review your history and retinal images at no cost.

Trusted nationwide. Thousands of clients. Millions recovered. No fees unless we win.

Ribbon Award Icon

35+ Years of Experience

Since 1993, trusted nationwide
Ribbon Award Icon

$100M+ Recovered to Clients

Product liability & mass torts
Ribbon Award Icon

No Fees Unless We Win

You pay nothing upfront
Ribbon Award Icon

Nationwide Representation

Clients in all 50 states